Filing Details

Accession Number:
0001179110-10-017565
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-15 16:16:11
Reporting Period:
2010-12-14
Filing Date:
2010-12-15
Accepted Time:
2010-12-15 16:16:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884629 Watson Pharmaceuticals Inc WPI Pharmaceutical Preparations (2834) 953872914
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242066 Todd R Joyce C/O Watson Pharmaceuticals, Inc.
311 Bonnie Circle
Corona CA 92880
Sr Vice Pres. & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0033 Acquisiton 2010-12-14 8,715 $46.31 41,882 No 4 M Direct
Common Stock, Par Value $0.0033 Acquisiton 2010-12-14 1,285 $46.31 43,167 No 4 M Direct
Common Stock, Par Value $0.0033 Disposition 2010-12-14 5,000 $49.70 38,167 No 4 S Direct
Common Stock, Par Value $0.0033 Disposition 2010-12-14 3,715 $49.50 34,452 No 4 S Direct
Common Stock, Par Value $0.0033 Disposition 2010-12-14 1,285 $49.50 33,167 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.0033 Non-Qualified Options to Purchase Common Stock Disposition 2010-12-14 8,715 $0.00 8,715 $46.31
Common Stock, Par Value $0.0033 Incentive Stock Options to Purchase Common Stock Disposition 2010-12-14 1,285 $0.00 1,285 $46.31
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2005-12-15 2010-12-21 No 4 M Direct
0 2005-12-15 2010-12-21 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.0033 6,207 Indirect Trust
Footnotes
  1. Includes shares of restricted stock issued pursuant to the Third Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.